Publication | Closed Access
The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats.
11
Citations
0
References
2005
Year
NutritionAm 251Food IntakePharmacotherapyCannabinoid PharmacologyMolecular PharmacologyCannabinoidsAppetite ControlHealth SciencesCannabis UseCb1 Receptor AntagonistBiochemistryBehavioral PharmacologyNeuropharmacologyPharmacologyCannabisFunctional SelectivityPhysiologyMedicineDrug DiscoveryNeuropeptides
The anorectic effect of AM 251 (N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-di-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide), a CB1 receptor antagonist, was studied in rats. AM 251 (0.5-2.0 mg/kg i.p.) significantly and dose-dependently reduced food intake in both free-feeding and food-deprived rats. The obtained results support the anorectic activity of CB1 receptors antagonists.